Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Trial shows antiplatelet therapy needs personalization after stent implantation August 29, 2026 Denzel Ward encourages lifesaving Hands-Only CPR action across Cleveland May 29, 2026 Updated COVID-19 vaccines protect adults with autoimmune rheumatic conditions September 9, 2026